Relmada Therapeutics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (17)

View All

Latest Posts

About This Stock More About This Stock
E VistaGen Is Prepared For 2021 Fueled By Recent Analyst Upgrades And Large Institutional Buyers
Article By: Moon Kil Woong
Friday, January 8, 2021 11:59 AM EST
VistaGen’s deal with Pherin Pharmaceuticals to develop PH-94B has positioned the Company to grab a healthy share of, social anxiety, and major depression markets.
In this article: JNJ, SAGE, CNSP, AXSM, RLMD, VTGN
Read
An Interview With Relmada Therapeutics
Article By: Jason Napodano
Thursday, October 13, 2016 12:39 PM EST
This is a transcript of an interview I did with the management team at Relmada Therapeutics.
In this article: RLMD Also: AGN, JNJ
Read
Relmada Therapeutics Launches Pharmaceutical Armada Against Chronic Pain And Opioid Abuse
Article By: The Life Sciences Report
Tuesday, April 26, 2016 5:06 PM EST
Relmada's Therapeutics Inc. Michael Becker describes the company's programs, which are advancing steadily toward the marketplace.
In this article: RLMD Also: AGN, ENDP, BDSI
Read
All Posts

Latest Tweets for $RLMD

No tweets yet!